Browse > Article
http://dx.doi.org/10.5483/BMBRep.2019.52.11.018

CpG-DNA induces bacteria-reactive IgM enhancing phagocytic activity against Staphylococcus aureus infection  

Kim, Te Ha (Department of Microbiology, College of Medicine, Hallym University)
Kim, Dongbum (Center for Medical Science Research, College of Medicine, Hallym University)
Lee, Heesu (Department of Microbiology, College of Medicine, Hallym University)
Kwak, Min Hyung (Department of Microbiology, College of Medicine, Hallym University)
Park, Sangkyu (Department of Biochemistry, College of Natural Sciences, Chungbuk National University)
Lee, Younghee (Department of Biochemistry, College of Natural Sciences, Chungbuk National University)
Kwon, Hyung-Joo (Department of Microbiology, College of Medicine, Hallym University)
Publication Information
BMB Reports / v.52, no.11, 2019 , pp. 635-640 More about this Journal
Abstract
CpG-DNA triggers the proliferation and differentiation of B cells which results in the increased production of antibodies. The presence of bacteria-reactive IgM in normal serum was reported; however, the relevance of CpG-DNA with the production of bacteria-reactive IgM has not been investigated. Here, we proved the function of CpG-DNA for the production of bacteria-reactive IgM. CpG-DNA administration led to increased production of bacteria-reactive IgM both in the peritoneal fluid and serum through TLR9 signaling pathway. When we stimulated B cells with CpG-DNA, production of bacteria-reactive IgM was reproduced in vitro. We established a bacteria-reactive monoclonal IgM antibody using CpG-DNA stimulated-peritoneal B cells. The monoclonal IgM antibody enhanced the phagocytic activity of RAW 264.7 cells against S. aureus MW2 infection. Therefore, we suggest that CpG-DNA enhances the antibacterial activity of the immune system by triggering the production of bacteria-reactive IgM. We also suggest the possible application of the antibodies for the treatment of antibiotics-resistant bacterial infections.
Keywords
CpG-DNA; IgM; Phagocytosis; Staphylococcus aureus; TLR9;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Wu HM, Wang J, Zhang B, Fang L, Xu K and Liu RY (2016) CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage. Life Sci 161, 51-59   DOI
2 Kim TH, Kim D, Gautam A et al (2018) CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies. Sci Rep 8, 16236   DOI
3 Adem PV, Montgomery CP, Husain AN et al (2005) Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 353, 1245-1251   DOI
4 Neu HC (1992) The crisis in antibiotic resistance. Science 257, 1064-1073   DOI
5 Schaffer AC and Lee JC (2008) Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents 32 Suppl 1, S71-78   DOI
6 Fattom AI, Horwith G, Fuller S, Propst M and Naso R (2004) Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Vaccine 22, 880-887   DOI
7 Vernachio J, Bayer AS, Le T et al (2003) Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob Agents Chemother 47, 3400-3406   DOI
8 Zhou ZH, Zhang Y, Hu YF, Wahl LM, Cisar JO and Notkins AL (2007) The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1, 51-61   DOI
9 Hoffman W, Lakkis FG and Chalasani G (2016) B Cells, Antibodies, and More. Clin J Am Soc Nephrol 11, 137-154   DOI
10 Cole LE, Yang Y, Elkins KL et al (2009) Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc Natl Acad Sci U S A 106, 4343-4348   DOI
11 Panda S, Zhang J, Tan NS, Ho B and Ding JL (2013) Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. EMBO J 32, 2905-2919   DOI
12 Park BK, Maharjan S, Lee SI et al (2018) Generation and characterization of a monoclonal antibody against MERSVoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex. BMB Rep 52, 397-402   DOI
13 Kim DW, Shin MJ, Choi YJ et al (2018) Tat-ATOX1 inhibits inflammatory responses via regulation of MAPK and NF-kB pathways. BMB Rep 51, 654-659   DOI
14 Boes M (2000) Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37, 1141-1149   DOI
15 Casali P and Schettino EW (1996) Structure and function of natural antibodies. Curr Top Microbiol Immunol 210, 167-179
16 Hjelm F, Carlsson F, Getahun A and Heyman B (2006) Antibody-mediated regulation of the immune response. Scand J Immunol 64, 177-184   DOI
17 Ehrenstein MR and Notley CA (2010) The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10, 778-786   DOI
18 Ricci ML, von Hunolstein C, Gomez MJ, Parisi L, Tissi L and Orefici G (1996) Protective activity of a murine monoclonal antibody against acute and chronic experimental infection with type IV group B streptococcus. J Med Microbiol 44, 475-481   DOI
19 Connolly SE, Thanassi DG and Benach JL (2004) Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia. J Immunol 172, 1191-1197   DOI
20 Hustinx W, Benaissa-Trouw B, Van Kessel K et al (1997) Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis. Eur J Clin Invest 27, 1044-1048   DOI
21 Kinoshita M, Shinomiya N, Ono S et al (2006) Restoration of natural IgM production from liver B cells by exogenous IL-18 improves the survival of burn-injured mice infected with Pseudomonas aeruginosa. J Immunol 177, 4627-4635   DOI
22 Schwartz JT, Barker JH, Long ME, Kaufman J, McCracken J and Allen LA (2012) Natural IgM mediates complementdependent uptake of Francisella tularensis by human neutrophils via complement receptors 1 and 3 in nonimmune serum. J Immunol 189, 3064-3077   DOI
23 Brown JS, Hussell T, Gilliland SM et al (2002) The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A 99, 16969-16974   DOI
24 Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT and Leong JM (2003) The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol 170, 3819-3827   DOI
25 Klinman DM, Yi AK, Beaucage SL, Conover J and Krieg AM (1996) CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A 93, 2879-2883   DOI
26 Krieg AM, Yi AK, Matson S et al (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549   DOI
27 Mohamed W, Domann E, Chakraborty T et al (2016) TLR9 mediates S. aureus killing inside osteoblasts via induction of oxidative stress. BMC Microbiol 16, 230   DOI
28 Deng JC, Moore TA, Newstead MW, Zeng X, Krieg AM and Standiford TJ (2004) CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J Immunol 173, 5148-5155   DOI
29 Ishii KJ, Ito S, Tamura T et al (2005) CpG-activated Thy1.2+ dendritic cells protect against lethal Listeria monocytogenes infection. Eur J Immunol 35, 2397-2405   DOI